Actively Recruiting
Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
Led by Akron Children's Hospital · Updated on 2025-01-13
60
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.
CONDITIONS
Official Title
Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females
- Undergoing primary posterior spinal fusion of the thoracic and/or lumbar spine
- English Speaking
You will not qualify if you...
- Patients who have undergone prior spinal surgery
- Undergoing procedures other than primary posterior spinal fusion of the thoracic and/or lumbar spine (cervical fusion, anterior surgery, growth-friendly instrumentation)
- Any contraindication to povidone-iodine, including pregnancy, allergy, or prior treatment with radioiodine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Akron Children's Hospital
Akron, Ohio, United States, 44308
Actively Recruiting
Research Team
A
Alexandria Rundell, BS
CONTACT
L
Lorena Floccari, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here